TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Astellas Pharma AB
Closing information (x1000 NOK)
| Closing information | 2025/03 | 2024/03 | 2023/03 |
| Turnover |
52,254
|
38,583
|
44,003 |
| Financial expenses |
194
|
70
|
159 |
| Earnings before taxes |
1,113
|
877
|
2,006 |
| EBITDA |
1,044
|
597
|
2,165 |
| Total assets |
91,019
|
72,265
|
56,356 |
| Current assets |
91,019
|
72,265
|
56,356 |
| Current liabilities |
48,360
|
31,459
|
18,358 |
| Equity capital |
42,659
|
40,806
|
37,998 |
| - share capital |
265
|
258
|
249 |
| Employees (average) |
11
|
16
|
16 |
Financial ratios
| Fiscal year | 2025/03 | 2024/03 | 2023/03 |
| Solvency |
46.9%
|
56.5%
|
67.4% |
| Turnover per employee |
4,750
|
2,411
|
2,750 |
| Profit as a percentage of turnover |
2.1%
|
2.3%
|
4.6% |
| Return on assets (ROA) |
1.4%
|
1.3%
|
3.8% |
| Current ratio |
188.2%
|
229.7%
|
307.0% |
| Return on equity (ROE) |
2.6%
|
2.1%
|
5.3% |
| Change turnover |
12,269
|
-5,880
|
2,662 |
| Change turnover % |
31%
|
-13%
|
6% |
| Chg. No. of employees |
-5
|
0
|
-2 |
| Chg. No. of employees % |
-31%
|
0%
|
-11% |
Total value of public sale
| Fiscal year | 2025/03 | 2024/03 | 2023/03 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.